Found 13 matching trials
Efficacy, Safety and PK/PD of MOR202 in Anti-PLA2R+ Membranous Nephropathy (aMN) (NewPLACE) PHASE2 This 2-arm, multi-center, open-label, parallel-group phase II trial will as...
Show More Location
Managadze National Center of Urology
Learn More & Join Trial
A Phase 1/2a Study of Human Anti-CD 38 Antibody MOR03087 (MOR202) in Relapsed/Refractory Multiple Myeloma PHASE1 This is an open-label, multicentre, dose escalation study to characterize t...
Show More Location
AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I
Learn More & Join Trial
A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN) PHASE3 In this study, researchers will learn more about the use of felzartamab in ...
Show More Location
Applied Research Center of Arkansas
Learn More & Join Trial
MOR202 for Refractory MN PHASE2 Membranous nephropathy (MN) - the leading cause of nephrotic syndrome (NS) ...
Show More Location
ASST HPG23 - Unità di Nefrologia
Learn More & Join Trial
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) PHASE3 In this study, researchers will learn more about the use of felzartamab in ...
Show More Status
Active Not Recruiting
Location
University of Southern California
Learn More & Join Trial
A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN) PHASE3 In this study, researchers will learn more about the use of felzartamab in ...
Show More Location
Apogee Clinical Research, LLC
Learn More & Join Trial
A Study to Learn About the Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Late Isolated Microvascular Inflammation PHASE2 In this study, researchers will learn more about a drug called felzartamab ...
Show More Location
Loma Linda University Medical Center
Learn More & Join Trial
A Study to Learn More About the Long-Term Safety and Effects of Felzartamab Infusions in Adults With Kidney Transplants Who Have Antibody-Mediated Rejection (AMR) or Microvascular Inflammation (MVI) (TRANSCEND/TRANSPIRE LTE) PHASE3 In this study, researchers will learn more about a drug called felzartamab ...
Show More Status
Enrolling By Invitation
Location
Keck Medical Center of USC
Learn More & Join Trial
A Study to Learn About The Effects of Felzartamab on Thyroid Function and Its Safety in Adults With Graves' Disease Ages 18 to 75 Years Old PHASE2 In this study, researchers will learn more about the use of felzartamab in ...
Show More Location
AME Clinical Research
Learn More & Join Trial
Clinical Trial to Assess Efficacy and Safety of the Human Anti-CD38 Antibody Felzartamab (MOR202) in IgA Nephropathy PHASE2 Randomized, placebo-controlled, multi-center, double-blind, proof of concep...
Show More Location
FOMAT Medical Research - FOMAT - HyperCore - PPDS
Learn More & Join Trial